Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Vigil Neuroscience, Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-18
Sale
2022-11-22
9:45 pm
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$14$4,200153,604
(Direct)
View
2022-05-16
Purchase
2022-05-17
9:06 pm
Vigil Neuroscience Inc.VIGLThorp Clay
Director
36,695$2.8454$104,4111,559,030
(Indirect
Direct)
View
2022-05-05
Purchase
2022-05-06
07:00 am
Vigil Neuroscience Inc.VIGLThackaberry Evan
SVP, Head of Early Development
1,500$4$6,0001,500
(Direct)
View
2022-05-03
Purchase
2022-05-04
07:00 am
Vigil Neuroscience Inc.VIGLVerni Christopher
General Counsel
4,000$3.7686$15,0744,000
(Direct)
View
2022-05-02
Purchase
2022-05-04
07:00 am
Vigil Neuroscience Inc.VIGLMagovcevic-Liebisch Ivana
President and CEO
5,000$3.6758$18,379203,687
(Direct)
View
2022-05-03
Purchase
2022-05-04
07:00 am
Vigil Neuroscience Inc.VIGLZiolkowski Jennifer Lynn
Chief Financial Officer
4,000$3.7744$15,0984,000
(Direct)
View
2022-05-03
Purchase
2022-05-04
07:00 am
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
4,000$3.3978$13,5914,000
(Direct)
View
2022-03-28
Purchase
2022-03-28
4:44 pm
Vigil Neuroscience Inc.VIGLThorp Clay
Director
3,000$7.2014$21,6041,522,335
(Indirect
Direct)
View
2022-01-11
Purchase
2022-01-11
9:20 pm
Vigil Neuroscience Inc.VIGLThorp Clay
Director
265,000$14$3,710,0001,519,335
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-08
Option Award
2023-05-09
4:10 pm
N/A
2033-05-07
Vigil Neuroscience Inc.VIGLBudd Haeberlein Samantha L.
Director
30,694$030,694
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:14 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLMagovcevic-Liebisch Ivana
President and CEO
370,000$0370,000
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:13 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLBruhn Suzanne Louise
Director
6,235$7.6186,235
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:12 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLBooth Bruce
Director
9,713$7.6189,713
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:11 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLVerni Christopher
General Counsel
85,000$085,000
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:08 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLThackaberry Evan
SVP, Head of Early Development
65,000$065,000
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:08 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLBlanchard Cheryl R
Director
6,432$7.6186,432
(Direct)
View
2023-03-01
Option Award
2023-03-03
5:08 pm
N/A
2033-03-01
Vigil Neuroscience Inc.VIGLZiolkowski Jennifer Lynn
Chief Financial Officer
135,000$0135,000
(Direct)
View
2023-02-27
Option Award
2023-02-27
7:04 pm
N/A
2033-02-26
Vigil Neuroscience Inc.VIGLGray David L. F.
Chief Science Officer
267,000$0267,000
(Direct)
View
2022-11-18
Exercise
2022-11-22
9:45 pm
N/A
N/A
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$1.89153,604
(Direct)
View
2022-11-18
Exercise
2022-11-22
9:45 pm
N/A
2030-11-18
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$0153,604
(Direct)
View
2022-07-27
Option Award
2022-07-28
08:36 am
N/A
2032-07-26
Vigil Neuroscience Inc.VIGLBruhn Suzanne Louise
Director
24,310$024,310
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:06 pm
N/A
2032-06-09
Vigil Neuroscience Inc.VIGLVitorovic Stefan
Director
12,155$05,028,084
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:05 pm
N/A
2032-06-09
Vigil Neuroscience Inc.VIGLKoenig Gerhard
Director
12,155$012,155
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:05 pm
N/A
2032-06-09
Vigil Neuroscience Inc.VIGLBlanchard Cheryl R
Director
12,155$012,155
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:05 pm
N/A
2032-06-09
Vigil Neuroscience Inc.VIGLBooth Bruce
Director
12,155$05,849,029
(Direct)
View
2022-06-09
Option Award
2022-06-13
4:05 pm
N/A
2032-06-09
Vigil Neuroscience Inc.VIGLThistle Mary
Director
12,155$012,155
(Direct)
View
2022-04-19
Option Award
2022-04-20
6:06 pm
N/A
2032-04-19
Vigil Neuroscience Inc.VIGLVerni Christopher
General Counsel
150,000$0150,000
(Direct)
View
2022-04-18
Option Award
2022-04-20
6:02 pm
N/A
2032-04-18
Vigil Neuroscience Inc.VIGLThistle Mary
Director
24,309$024,309
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:06 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLKoenig Gerhard
Director
4,351$9.634,351
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:06 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLMagovcevic-Liebisch Ivana
President and CEO
282,000$0282,000
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLBooth Bruce
Director
7,577$9.637,577
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyridon
Chief Medical Officer
75,500$075,500
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLThackaberry Evan
SVP, Head of Early Development
45,000$045,000
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLBlanchard Cheryl R
Director
5,017$9.635,017
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLZiolkowski Jennifer Lynn
Chief Financial Officer
110,000$0110,000
(Direct)
View
2022-01-11
Conversion
2022-01-13
4:06 pm
N/A
N/A
Vigil Neuroscience Inc.VIGLCormorant Asset Management LP
Chen Bihua
Cormorant Global Healthcare Master Fund LP
Cormorant Private Healthcare Fund IV LP
Former 10% Owner
616,786$0616,786
(Indirect)
View
2022-01-11
Conversion
2022-01-11
9:33 pm
N/A
N/A
Vigil Neuroscience Inc.VIGLAMGEN INC
10% Owner
3,206,281$03,206,281
(Direct)
View
2022-01-11
Conversion
2022-01-11
9:20 pm
N/A
N/A
Vigil Neuroscience Inc.VIGLThorp Clay
Director
4,732,862$01,519,335
(Indirect)
View
Goto 0, 1, Next